These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 1421370

  • 1. Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group.
    Reiter A, Schrappe M, Ludwig WD, Lampert F, Harbott J, Henze G, Niemeyer CM, Gadner H, Müller-Weihrich S, Ritter J.
    Blood; 1992 Nov 15; 80(10):2471-8. PubMed ID: 1421370
    [Abstract] [Full Text] [Related]

  • 2. Therapy of B-cell acute lymphoblastic leukaemia in childhood: the BFM experience.
    Reiter A.
    Baillieres Clin Haematol; 1994 Jun 15; 7(2):321-37. PubMed ID: 7803904
    [Abstract] [Full Text] [Related]

  • 3. Improved outcome in adult B-cell acute lymphoblastic leukemia.
    Hoelzer D, Ludwig WD, Thiel E, Gassmann W, Löffler H, Fonatsch C, Rieder H, Heil G, Heinze B, Arnold R, Hossfeld D, Büchner T, Koch P, Freund M, Hiddemann W, Maschmeyer G, Heyll A, Aul C, Faak T, Kuse R, Ittel TH, Gramatzki M, Diedrich H, Kolbe K, Fuhr HG, Fischer K, Schadeck-Gressel C, Weiss A, Strohscheer I, Metzner B, Fabry U, Gökbuget N, Völkers B, Messerer D, Uberla K.
    Blood; 1996 Jan 15; 87(2):495-508. PubMed ID: 8555471
    [Abstract] [Full Text] [Related]

  • 4. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi AM, Messina C, Mori PG, Miniero R, Colella R, Basso G.
    J Clin Oncol; 1995 Oct 15; 13(10):2497-502. PubMed ID: 7595699
    [Abstract] [Full Text] [Related]

  • 5. Teniposide plus cytarabine as intensification therapy and in continuation therapy for advanced nonlymphoblastic lymphomas of childhood.
    Maluf PT, Odone Filho V, Cristofani LM, Britto JL, Almeida MT, Pontes E, Maksoud JG, Manissadjian A.
    J Clin Oncol; 1994 Sep 15; 12(9):1963-8. PubMed ID: 8083717
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
    Schrappe M, Reiter A, Henze G, Niemeyer C, Bode U, Kühl J, Gadner H, Havers W, Plüss H, Kornhuber B, Zintl F, Ritter J, Urban C, Niethammer D, Riehm H.
    Klin Padiatr; 1998 Sep 15; 210(4):192-9. PubMed ID: 9743952
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study.
    Bowman WP, Shuster JJ, Cook B, Griffin T, Behm F, Pullen J, Link M, Head D, Carroll A, Berard C, Murphy S.
    J Clin Oncol; 1996 Apr 15; 14(4):1252-61. PubMed ID: 8648381
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Importance of effective central nervous system therapy in isolated bone marrow relapse of childhood acute lymphoblastic leukemia. BFM (Berlin-Frankfurt-Münster) Relapse Study Group.
    Bührer C, Hartmann R, Fengler R, Schober S, Arlt I, Loewke M, Henze G.
    Blood; 1994 Jun 15; 83(12):3468-72. PubMed ID: 8204875
    [Abstract] [Full Text] [Related]

  • 13. Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children.
    Spreafico F, Massimino M, Luksch R, Casanova M, Cefalo GS, Collini P, Ferrari A, Polastri D, Terenziani M, Gasparini M, Fossati-Bellani F.
    J Clin Oncol; 2002 Jun 15; 20(12):2783-8. PubMed ID: 12065554
    [Abstract] [Full Text] [Related]

  • 14. [NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphoma in children and adolescents. Part 3: An intermediate term analysis of the B-NHL/B-ALL].
    Reiter A, Schrappe M, Yakisan E, Sauter S, Ebell W, Zimmermann M, Hartmann W, Kremens B, Kuhn N, Claviez A.
    Klin Padiatr; 1994 Jun 15; 206(4):242-52. PubMed ID: 7967420
    [Abstract] [Full Text] [Related]

  • 15. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
    Reiter A, Schrappe M, Parwaresch R, Henze G, Müller-Weihrich S, Sauter S, Sykora KW, Ludwig WD, Gadner H, Riehm H.
    J Clin Oncol; 1995 Feb 15; 13(2):359-72. PubMed ID: 7844597
    [Abstract] [Full Text] [Related]

  • 16. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL, Marton E, Plander M, Gyánó G, Czumbil L, Tóth C.
    Orv Hetil; 2009 Oct 18; 150(42):1937-44. PubMed ID: 19812012
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group.
    Henze G, Fengler R, Hartmann R, Kornhuber B, Janka-Schaub G, Niethammer D, Riehm H.
    Blood; 1991 Sep 01; 78(5):1166-72. PubMed ID: 1878583
    [Abstract] [Full Text] [Related]

  • 20. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study.
    Dopfer R, Henze G, Bender-Götze C, Ebell W, Ehninger G, Friedrich W, Gadner H, Klingebiel T, Peters C, Riehm H.
    Blood; 1991 Nov 15; 78(10):2780-4. PubMed ID: 1824271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.